SEC Form 4 · accession 0001144204-19-011646
Cellectar Biosciences, Inc. · CLRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jarrod Longcor
Officer — Chief Business Officer
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2019 | P | 100 | $2.0025 | A | 7,300 | D |
Table II — derivative securities
No Table II lines on this filing.